Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523596 · ClinicalTrials.gov registry record · Phase 1
A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults
A Phase 1 study of Safety Issues, sponsored by IC-MedTech Corporation.
- Active
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
- 3
- Study locations
NCT05523596 is a Phase 1 study of Safety Issues that is active but no longer recruiting, run by IC-MedTech Corporation. The registered enrollment target is 13 participants, below the 119-participant average among 13 other Safety Issues trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05523596, a Phase 1 study of Safety Issues, is active but no longer recruiting, sponsored by IC-MedTech Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
- 3
- Study locations
Study Summary
A Phase 1 Non-Randomized Open Label Study of Oral ICM20
Conditions Studied
Interventions
- DRUG Benznidazole
- DRUG ICM20
Study Locations (3)
Maryland
- Parkway Medical - Glen Burnie
Texas
- Baylor College of Medicine - Houston
Virginia
- Culmore Clinic - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-12-20 |
| Est. Completion | 2027-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05523596
The ClinicalTrials.gov registry entry for NCT05523596 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 13 other Safety Issues trials with a reported enrollment target (89% lower). The listed sponsor is IC-MedTech Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Safety Issues appearing as the primary indexed condition, and to 2 interventions - of which Benznidazole is the first listed.
NCT05523596 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, Texas, Virginia.
Frequently Asked Questions
What is clinical trial NCT05523596 about?
NCT05523596 is a clinical study titled "A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults". A Phase 1 Non-Randomized Open Label Study of Oral ICM20
What is the current status of trial NCT05523596?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2022-12-20. Estimated completion is 2027-03.
What conditions does trial NCT05523596 study?
This clinical trial studies the following conditions: Safety Issues.
What interventions are being tested in trial NCT05523596?
The interventions under investigation include: Benznidazole (DRUG), ICM20 (DRUG).
Who is sponsoring clinical trial NCT05523596?
This trial is sponsored by IC-MedTech Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05523596 being conducted?
This trial has 3 study locations across Maryland, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Safety Issues
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis
ACTIVE NOT RECRUITING · Phase 1
-
A Phase 1 Study of EXT608 in Healthy Adults
COMPLETED · Phase 1
-
Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study
COMPLETED · Phase 1
-
Oral Remimazolam With and Without Alcohol in Healthy Female Subjects
COMPLETED · Phase 1
-
Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.